Follow
ImmuneBiotech Medical Sweden AB
Nasdaq First North GM (Sweden)
ImmuneBiotech discovers and develops novel probiotics for therapeutic effect based on lactic acid bacteria and symbiotic formulations targeting gut microbiota and the immune system. We deliver transformational solutions to modulate the microbiome, heal leaky gut and reduce inflammation to prevent and treat autoimmune and other chronic inflammatory conditions.
Sector:
HEALTH CARE
 
News
Nothing to display for this company
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
Nasdaq First North GM
Sweden (SE)
Details of share in ImmuneBiotech Medical Sweden AB with ticker
Status
Inactive
Order book id
Amount of instruments
Par value
Currency
SEK
Type
Price
Pre-money valuation
Time
Files
Listing
2021
Direct listing of ImmuneBiotech Medical Sweden AB on Nasdaq First North GM
People
Shahram Lavasani
CEO
Mehrnaz Nouri
Board member
Derek Batcheller
Board member
Shahram Lavasani
Board member
Company Details
Sector
HEALTH CARE

Address
Scheelevägen 2
Zip code
223 81
City/district
Lund
Country
Sweden (SE)
Registration number
556939-2813
LEI code
First trade date
Registration date
15 Aug 2013
Short name
ImmuneBiotech

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More